Baltic and Eurasia Masterclass in Clinical Oncology


 

Advanced Breast Cancer: Endocrine Therapy as Preferred Option for HR(+) & Review of CDK4/6 Inhibitors and PIK3CA- Mutant Cohort Trials

405 views
August 1, 2019
Comments 0
Login to view comments. Click here to Login